Mumbai, India – Indian stocks closed higher on Thursday, driven by buyers who chased value picks in IT, metals, and public‑sector banks. A boost in the pharma sector helped the Nifty Pharma index climb 228 points, or 1.05 %, after the U.S. announced it would not impose tariffs on generic drug imports.
The Sensex finished at 82,172.10, up 398.44 points or 0.49 %. It opened the day with a gap‑up to 81,900 from yesterday’s close of 81,773.66 and hit an intraday high of 82,247.73 as investors bought across the board. Meanwhile, the Nifty ended at 25,181.80, up 135 points or 0.54 %.
Analysts noted the market is on a bullish trend. “The Nifty is holding above its 21‑day moving average near 25,000, and if it stays above that level we could see the index push toward 25,400 in the October series,” said a market analyst.
Top gainers in the Sensex basket included Tata Steel, HCL Technologies, Ultratech Cement, BEL, Sun Pharma, Eternal, Trent, Tata Consultancy Services, Kotak Mahindra Bank, Larsen & Toubro, Infosys, Hindustan Unilever, and NTPC. Axis Bank, Titan, and HDFC Bank fell a bit.
Sector performance was broadly positive. The Nifty Financial Services index rose 67 points (0.25 %), Nifty Bank jumped 173 points (0.31 %), Nifty Auto up 64 points (0.24 %), Nifty FMCG gained 217 points (0.40 %), and Nifty IT added 396 points (1.12 %). Small‑cap, mid‑cap, and overall Nifty 100 indices also posted gains, with the Nifty Smallcap 100 up 109 points (0.61 %) and Nifty Midcap 100 rising 563 points (0.97 %).
The Indian rupee traded flat at 88.76 against the dollar, showing little volatility after a period of sharp swings. FII selling eased and crude oil prices stayed within a narrow range.
“There’s still pressure on the rupee to stay near its lower levels, which could push it toward the 90 mark if global sentiment weakens,” said Jateen Trivedi of LKP Securities. “In the next few days, investors will focus on Fed Chair Jerome Powell’s speech and key U.S. data on unemployment and payrolls, which could stir forex volatility.”
The market’s steady climb in India’s major indices reflects confidence in domestic growth, value stocks, and a hopeful outlook for the pharma sector amid evolving U.S. trade policies.
Source: ianslive
Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in world News on Latest NewsX. Follow us on social media Facebook, Twitter(X), Gettr and subscribe our Youtube Channel.
